{"id":8010,"date":"2015-01-04T13:24:41","date_gmt":"2015-01-04T12:24:41","guid":{"rendered":"http:\/\/mileon.wordpress.com\/?p=8010"},"modified":"2015-01-04T13:24:41","modified_gmt":"2015-01-04T12:24:41","slug":"utilizacion-actual-de-los-glucopeptidos","status":"publish","type":"post","link":"https:\/\/www.icscyl.com\/mileon\/residentes\/2015-01-04\/utilizacion-actual-de-los-glucopeptidos\/","title":{"rendered":"Utilizaci\u00f3n actual de los glucop\u00e9ptidos."},"content":{"rendered":"<p style=\"text-align:justify;\"><a href=\"https:\/\/mileon.files.wordpress.com\/2015\/01\/imagen.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"  wp-image-8011 alignright\" src=\"https:\/\/mileon.files.wordpress.com\/2015\/01\/imagen.jpg\" alt=\"imagen\" width=\"222\" height=\"183\" \/><\/a>El 29 de diciembre de 2014 el Dr. Diego L\u00f3pez Su\u00e1rez (Residente de 4\u00ba de Farmacia Hospitalaria) actualiz\u00f3 el tema del uso de los glucop\u00e9ptidos enfocado principalmente en la vancomicina que sigue teniendo su papel junto a las otras opciones terap\u00e9uticas, como nos indican las gu\u00edas actuales. Su toxicidad es distinta al de otras alternativas y su coste bajo.<\/p>\n<p style=\"text-align:justify;\">Su presentaci\u00f3n se puede visualizar en el siguiente\u00a0<a href=\"https:\/\/drive.google.com\/file\/d\/0BxXYCqMXR4ZaS0luUkRQRzF0dXM\/view?usp=sharing\">enlace.<\/a><\/p>\n<p style=\"text-align:justify;\">\n<p style=\"text-align:justify;\">\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>El 29 de diciembre de 2014 el Dr. Diego L\u00f3pez Su\u00e1rez (Residente de 4\u00ba de Farmacia Hospitalaria) actualiz\u00f3 el tema del uso de los glucop\u00e9ptidos enfocado principalmente en la vancomicina que sigue teniendo su papel junto a las otras opciones terap\u00e9uticas, como nos indican las gu\u00edas actuales. Su toxicidad es distinta al de otras alternativas [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[721],"tags":[824],"class_list":["post-8010","post","type-post","status-publish","format-standard","hentry","category-residentes","tag-diego"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/posts\/8010","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/comments?post=8010"}],"version-history":[{"count":0,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/posts\/8010\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/media?parent=8010"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/categories?post=8010"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/tags?post=8010"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}